SeqLL Awarded SBIR to advance the development of Direct RNA Sequencing (DRS™) technology
Tuesday, July 11, 2017 WOBURN, MA — SeqLL, LLC announced today that it has been awarded a Phase I SBIR grant in the amount of $223,465 by the NIH/National Human Genome Research Institute to [...]